公司资料
Invitae 股价、新闻与催化剂
- 股票代码:
- NVTA
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for NVTA.
公司概览
业务概览
Invitae was a genetic-testing company focused on broad clinical genetic information and testing services before its restructuring and public-market exit. Its business was built around access to genetic data at scale.
所在地与行业分类
Headquartered in the United States and listed on NYSE before restructuring, Invitae sat in diagnostics and genomics.
商业模式特征
The company depended on test volume, reimbursement, and the challenge of scaling consumer and clinical genetics.
生物医药行业定位
Invitae is now best viewed as a legacy genomics company rather than a live public-market catalyst story.
未来催化剂
- Invitae is now mostly a legacy genetics and restructuring story, so the catalysts are balance-sheet, strategic, and closeout related rather than pipeline-driven. Investors will care about whatever clarifies the company’s end state.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。